Capital Signal

Chimeric Therapeutics Limited (ASX: CHM)

Sector: Health Care

Chimeric is a biotechnology company developing a cancer cell therapy drug

Data as of 8 Oct 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
23 Mar 2026Public offer$6M——Filing ↗
23 Dec 2025Placement$4.4M$0.000%Filing ↗
20 May 2025Placement$6.6M$0.0050% discountFiling ↗
24 Apr 2025Rights issue$1M$0.01—Filing ↗
22 Oct 2024Placement$4M$0.01—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
8 Oct 2026Magellan Financial Group Ltd (MFG) and each of its related bodies corporate listed in Part A and Part B of Annexure A.Exit—Filing ↗
6 Oct 2026Magellan Financial Group Ltd (MFG) and each of its related bodies corporate listed in Part A and Part B of Annexure A (Barrenjoey Group)Entry?% → 5.46%Filing ↗
5 May 2026GKCC LLCIncrease15.800% → 26.800%Filing ↗
9 Jan 2026GKCC LLCIncrease10.600% → 15.800%Filing ↗
5 Jan 2026Paul HopperExit—Filing ↗

Director trades — on-market

DateDirectorTradeSource
19 Aug 2025Miles PrinceBought 4,273,142Filing ↗
4 July 2022Dr. George MatchamBought 342,070 sharesFiling ↗
29 June 2022Leslie ChongBought 30,000 sharesFiling ↗
3 Dec 2021Paul HopperBought 375,000 sharesFiling ↗
2 Aug 2021Dr. George MatchamBought 500,000 sharesFiling ↗

Cash and runway

MetricValueAs ofSource
CashA$1M30 Sept 2026Filing ↗
Runway0.8 quarters30 Sept 2026Filing ↗

Ask about CHM in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has CHM raised money in the last year, and at what discount?
  • What was CHM's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading CHM…

Chimeric Therapeutics Limited (ASX: CHM): capital raises, holders, director trades | Capital Signal